Cost-effectiveness of maternal immunization against neonatal invasive Group B Streptococcus in the Netherlands
Background: Neonatal invasive Group B Streptococcus (GBS) infection causes considerable disease burden in the Netherlands. Intrapartum antibiotic prophylaxis (IAP) prevents early-onset disease (EOD), but has no effect on late-onset disease (LOD). A potential maternal GBS vaccine could prevent both EOD and LOD by conferring immunity in neonates. Objective: Explore under which circumstances maternal vaccination against GBS would be cost-effective as an addition to, or replacement for the current risk factor-based IAP prevention strategy in the Netherlands. Methods: We assessed the maximum cost-e... Mehr ...
Verfasser: |
Hahn, Brett A.
de Gier, Brechje
van Kassel, Merel N.
Bijlsma, Merijn W.
van Leeuwen, Elisabeth
Wouters, Maurice G.A.J.
van der Ende, Arie
van de Beek, Diederik
Wallinga, Jacco
Hahné, Susan J.M.
Jan van Hoek, Albert |
Dokumenttyp: |
Artikel |
Erscheinungsdatum: |
2021 |
Reihe/Periodikum: |
Hahn , B A , de Gier , B , van Kassel , M N , Bijlsma , M W , van Leeuwen , E , Wouters , M G A J , van der Ende , A , van de Beek , D , Wallinga , J , Hahné , S J M & Jan van Hoek , A 2021 , ' Cost-effectiveness of maternal immunization against neonatal invasive Group B Streptococcus in the Netherlands ' , Vaccine , vol. 39 , no. 21 , pp. 2876-2885 . https://doi.org/10.1016/j.vaccine.2021.04.001 |
Sprache: |
Englisch |
Permalink: |
https://search.fid-benelux.de/Record/base-26845627 |
Datenquelle: |
BASE;
Originalkatalog |
Powered By: |
BASE |
Link(s) :
|
https://research.vumc.nl/en/publications/144655a1-d1a2-4184-9bcd-879fe5a08074 |